Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Cost of Revenue: 2021-2024

Historic Cost of Revenue for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to $18.6 million.

  • Biofrontera's Cost of Revenue fell 58.07% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year increase of 10.41%. This contributed to the annual value of $18.6 million for FY2024, which is 6.67% up from last year.
  • As of FY2024, Biofrontera's Cost of Revenue stood at $18.6 million, which was up 6.67% from $17.4 million recorded in FY2023.
  • Over the past 5 years, Biofrontera's Cost of Revenue peaked at $18.6 million during FY2024, and registered a low of $520,000 during FY2021.
  • Moreover, its 3-year median value for Cost of Revenue was $17.9 million (2022), whereas its average is $18.0 million.
  • In the last 5 years, Biofrontera's Cost of Revenue soared by 3,342.31% in 2022 and then fell by 2.55% in 2023.
  • Biofrontera's Cost of Revenue (Yearly) stood at $520,000 in 2021, then surged by 3,342.31% to $17.9 million in 2022, then decreased by 2.55% to $17.4 million in 2023, then grew by 6.67% to $18.6 million in 2024.